UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study

Journal of clinical oncology, 2004-08, Vol.22 (16), p.3284-3292

2004

Volltextzugriff (PDF)

Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis

Journal of clinical oncology, 2017-01, Vol.35 (3), p.281-290

2017

Volltextzugriff (PDF)

Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial

Journal of clinical oncology, 2008-03, Vol.26 (8), p.1231-1238

2008

Volltextzugriff (PDF)

Enalapril to Prevent Cardiac Function Decline in Long-Term Survivors of Pediatric Cancer Exposed to Anthracyclines

Journal of clinical oncology, 2004-03, Vol.22 (5), p.820-828

2004

Volltextzugriff (PDF)

Phase I/II Trial of Temsirolimus Combined With Interferon Alfa for Advanced Renal Cell Carcinoma

Journal of clinical oncology, 2007-09, Vol.25 (25), p.3958-3964

2007

Volltextzugriff (PDF)

Effect of Doxorubicin Plus Cyclophosphamide on Left Ventricular Ejection Fraction in Patients With Breast Cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial

Journal of clinical oncology, 2004-09, Vol.22 (18), p.3700-3704

2004

Volltextzugriff (PDF)

DNA Damage and Repair Capacity in Patients With Lung Cancer: Prediction of Multiple Primary Tumors

Journal of clinical oncology, 2008-07, Vol.26 (21), p.3560-3566

2008

Volltextzugriff (PDF)

Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung Cancer

Journal of clinical oncology, 1999-02, Vol.17 (2), p.668-675

1999

Volltextzugriff (PDF)

LMCE3 Treatment Strategy: Results in 99 Consecutively Diagnosed Stage 4 Neuroblastomas in Children Older Than 1 Year at Diagnosis

Journal of clinical oncology, 2000-02, Vol.18 (3), p.468-476

2000

Volltextzugriff (PDF)

NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology

Journal of clinical oncology, 1997-12, Vol.15 (12), p.3433-3440

1997

Volltextzugriff (PDF)

Using Health-Related Quality of Life Measures to Predict Cardiac Function in Survivors Exposed to Anthracyclines

Journal of clinical oncology, 2004-08, Vol.22 (15), p.3149-3155

2004

Volltextzugriff (PDF)

Phase 1b/II study of durvalumab (D) and tremelimumab (T) plus PET-adjudicated chemoradiation (CRT) in patients (Pts) with esophageal adenocarcinoma

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.355-355

2024

Volltextzugriff (PDF)

Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?

Journal of clinical oncology, 1991-06, Vol.9 (6), p.1037-1044

1991

Volltextzugriff (PDF)

Efficacy and toxicity of q 2 weeks versus weekly versus q 3 weeks docetaxel in metastatic castration-resistant prostate cancer (CRPC)

Journal of clinical oncology, 2013-02, Vol.31 (6_suppl), p.206-206

2013

Volltextzugriff (PDF)

Efficacy and toxicity of q 2 weeks docetaxel versus weekly versus q 3 weeks in metastatic castration-resistant prostate cancer (CRPC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e16087-e16087

2013

Volltextzugriff (PDF)

Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma: Final results

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4029-4029

2022

Volltextzugriff (PDF)

Effect of nivolumab on tumor growth rate (TGR) in metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.481-481

2017

Volltextzugriff (PDF)

Cabozantinib (C) exposure-response (ER) modeling of safety endpoints in patients (pts) with renal cell carcinoma (RCC) in the phase III METEOR study

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.447-447

2017

Volltextzugriff (PDF)

Prognosis of brain metastasis (BM) in metastatic renal cell carcinoma (mRCC): Experience from Gustave Roussy (IGR)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.4561-4561

2016

Volltextzugriff (PDF)

Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.226-226

2021

Volltextzugriff (PDF)

Everolimus (E) versus axitinib (A) as second-line therapy (2L) in metastatic renal cell carcinoma (mRCC): Retrospective experience at Gustave Roussy

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.527-527

2016

Volltextzugriff (PDF)

A new prognostic model of survival in second-line targeted therapy (TT) for metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e16113-e16113

2016

Volltextzugriff (PDF)

Inter and intra-tumor heterogeneity of PD-L1 and MET expression in metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4569-4569

2017

Volltextzugriff (PDF)

Tivo-3: A phase 3, randomized, controlled, multi-center, open-label study to compare tivozanib hydrochloride to sorafenib in subjects with refractory advanced renal cell carcinoma (RCC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS4600-TPS4600

2017

Volltextzugriff (PDF)

Medical therapy for renal cell cancer with pancreatic metastases: Experience of the Gustave Roussy Institute

Journal of clinical oncology, 2015-03, Vol.33 (7_suppl), p.503-503

2015

Volltextzugriff (PDF)

1 – 25 von 435

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(435)
Mit Volltextzugriff
(428)

Publikationsform

Artikel
(435)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(163)
Oncology
(163)
Science & Technology
(163)
Humans
(151)
Female
(125)
Biological And Medical Sciences
(122)
Medical Sciences
(122)
Middle Aged
(108)
Male
(95)
Adult
(88)
Aged
(88)
Tumors
(69)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(54)
Pharmacology. Drug Treatments
(49)
Antineoplastic Agents
(41)
Survival Analysis
(41)
Treatment Outcome
(41)
Aged, 80 And Over
(40)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(32)
Disease-Free Survival
(30)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study

Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis

Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial

Enalapril to Prevent Cardiac Function Decline in Long-Term Survivors of Pediatric Cancer Exposed to Anthracyclines

Phase I/II Trial of Temsirolimus Combined With Interferon Alfa for Advanced Renal Cell Carcinoma

Effect of Doxorubicin Plus Cyclophosphamide on Left Ventricular Ejection Fraction in Patients With Breast Cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial

DNA Damage and Repair Capacity in Patients With Lung Cancer: Prediction of Multiple Primary Tumors

Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung Cancer

LMCE3 Treatment Strategy: Results in 99 Consecutively Diagnosed Stage 4 Neuroblastomas in Children Older Than 1 Year at Diagnosis

NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology

Using Health-Related Quality of Life Measures to Predict Cardiac Function in Survivors Exposed to Anthracyclines

Phase 1b/II study of durvalumab (D) and tremelimumab (T) plus PET-adjudicated chemoradiation (CRT) in patients (Pts) with esophageal adenocarcinoma

Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?

Efficacy and toxicity of q 2 weeks versus weekly versus q 3 weeks docetaxel in metastatic castration-resistant prostate cancer (CRPC)

Efficacy and toxicity of q 2 weeks docetaxel versus weekly versus q 3 weeks in metastatic castration-resistant prostate cancer (CRPC)

Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma: Final results

Effect of nivolumab on tumor growth rate (TGR) in metastatic renal cell carcinoma (mRCC)

Cabozantinib (C) exposure-response (ER) modeling of safety endpoints in patients (pts) with renal cell carcinoma (RCC) in the phase III METEOR study

Prognosis of brain metastasis (BM) in metastatic renal cell carcinoma (mRCC): Experience from Gustave Roussy (IGR)

Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma

Everolimus (E) versus axitinib (A) as second-line therapy (2L) in metastatic renal cell carcinoma (mRCC): Retrospective experience at Gustave Roussy

A new prognostic model of survival in second-line targeted therapy (TT) for metastatic renal cell carcinoma (mRCC)

Inter and intra-tumor heterogeneity of PD-L1 and MET expression in metastatic renal cell carcinoma (mRCC)

Tivo-3: A phase 3, randomized, controlled, multi-center, open-label study to compare tivozanib hydrochloride to sorafenib in subjects with refractory advanced renal cell carcinoma (RCC)

Medical therapy for renal cell cancer with pancreatic metastases: Experience of the Gustave Roussy Institute

Aktive Filter

Suchergebnisse filtern